Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy-Reference-Cited by-同舟云学术

Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy

Published:2021 Issue:18 Volume:9 Page:3892-3899
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Su Qi¹²³⁴⁵,Wang Changrong⁶⁷⁸⁹¹⁰,Song Huijuan¹¹¹²¹³¹⁴¹⁰,Zhang Chuangnian¹⁵¹⁴¹⁰,Liu Jinjian¹¹¹²¹³¹⁴¹⁰,Huang Pingsheng¹⁵¹⁴¹⁰^ORCID,Zhang Yumin¹¹¹²¹³¹⁴¹⁰,Zhang Jianhuan¹²³⁴⁵^ORCID,Wang Weiwei¹⁵¹⁴¹⁰^ORCID

Affiliation:

1. Department of Polymer Science and Technology

2. Key Laboratory of Systems Bioengineering of the Ministry of Education

3. School of Chemical Engineering and Technology

4. Tianjin University

5. Tianjin 300072

6. School of Pharmacy

7. Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory

8. Binzhou Medical University

9. Yantai 264003

10. China

11. Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine

12. Institute of Radiation Medicine

13. Chinese Academy of Medical Sciences and Peking Union Medical College

14. Tianjin 300192

15. Tianjin Key Laboratory of Biomaterial Research Institute of Biomedical Engineering Chinese Academy of Medical Sciences and Peking Union Medical College

Abstract

Co-delivery of IDO inhibitor and anionic epitope/CpG vaccine using self-assembled cationic liposomes could amplify the antitumor immune response against melanoma.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Chinese Academy of Medical Sciences

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2021/TB/D1TB00256B

Reference47 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries